trending Market Intelligence /marketintelligence/en/news-insights/trending/pjiknj3qnoepodrfnjyema2 content esgSubNav
In This List

China Regenerative Medicine names COO

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


China Regenerative Medicine names COO

China Regenerative Medicine International Ltd. appointed Sun Xiaohu as COO, effective Oct. 10.

Xiaohu was previously operation director and marketing director of Chinese biotech Vcanbio.

Wan Chai, Hong Kong-based China Regenerative Medicine develops biomedical and healthcare products, as well as medical techniques.